WAF1/CIP1 (p21) in DNA repair and apoptosis following γ γ γ γ-irradiation remains controversial. In this study the influence of p21 on the radiosensitivity of human brain tumors was investigated. Resected tumors were stained immunohistochemically for p21. Expression of p21 in astrocytic tumors was high, but it was low in medulloblastomas, germinomas, and primary malignant lymphomas. Glioma and medulloblastoma cell lines were transfected with pcDNA/p21 to cause p21 overexpression, then tumor-cell colony formation and apoptosis were assessed following γ γ γ γ-irradiation of the transfected and nontransfected cells. Overexpression of p21 enhanced clonogenic survival and suppressed apoptosis after γ γ γ γ-irradiation in human brain tumor cell lines with or without p53 protein deficiency. Radioresistance was acquired when p21 was overproduced in the glioma cell lines irrespective of p53 status.
The recently cloned protein p21 WAF1/CIP1 (p21) is a key downstream mediator of wild-type p53 function in growth control and cell cycle progression, 1) forming multiple quaternary complexes with cyclins, cyclin-dependent kinases (cdk), and proliferating cell nuclear antigen (PCNA). [2] [3] [4] The p21 protein potently regulates the cell cycle by inhibiting cdk, which is required for progression from the G1 to the S phase, and also inhibits activation of DNA polymerase δ by PCNA, preventing DNA replication. Transcription of p21 is induced by overexpression of wild-type p53 1, 5) or by activation of p53 after DNA damage. 6) Upregulation of p21 may also be triggered by several differentiation-inducing agents in hematopoietic and other cells through p53-independent pathways. [7] [8] [9] Although p21 appears central to G1 arrest, participation of p21 in p53-dependent and p53-independent cell death remains controversial. Inhibition of p21 expression by transfection of p21 antisense oligonucleotides has been shown to interfere with growth factor-induced differentiation of SH-SY5Y neuroblastoma cells and to result in cell death. 10) In a tetracycline-inducible system using p53-deficient cells, p21 enhanced the cellular capacity to repair ultraviolet irradiation damage in reporter plasmids, 11) and HCT-116/p21 cells lacking the p21 gene exhibited greater sensitivity to cis-platinum and nitrogen mustard than the parent HCT-116 cells. 12) These results suggest that p21 may participate directly in modulating nucleotide excision repair of damage caused by cis-platinum, nitrogen mustard, or ultraviolet exposure.
In contrast to ultraviolet irradiation or cis-platinum, DNA damage induced by γ-irradiation generates DNA strand breaks and other types of DNA damage that are repaired primarily by mechanisms not involving nucleotide excision repair. Another proposed mechanism of processing of DNA damage induced by γ-irradiation is apoptosis via p53-dependent or p53-independent pathways. [13] [14] [15] [16] Recently, HCT-116/p21 −/− cells have been found to be more readily killed by γ-irradiation than their p21 +/+ counterparts. 17) More recently, in DLD-1 human colorectal carcinoma cells, mutant p21 lacking any cdk-inhibitory activity failed to prevent apoptosis induced by γ-irradiation or adriamycin. 18) However, another study using HCT-116 cells found that the clonogenic survival of cells exposed to γ-irradiation was not affected by p21 disruption. 19) Whether p21 protects cells against death from γ-irradiation remains to be established.
In the present study, we investigated the role of p21 in determining the radiosensitivity of human brain tumors. Glial tumors, the most common primary central nervous system tumors, are resistant to γ-irradiation. 20, 21) Although p21 is frequently overexpressed in astrocytomas, anaplastic astrocytomas, and glioblastomas, 22) p21 expression has not been examined in radiosensitive brain tumors such as medulloblastoma, 23) germinoma, 24) and primary malignant lymphoma. 25) We found greater p21 expression in radioresistant astrocytic tumors than in more radiosensitive brain tumors. We also noted that overexpression of p21 increased radioresistance in brain tumor cell lines with or without wild-type p53. Our results suggest that p21 facilitates tumor cell survival in human gliomas with DNA damage induced by γ-irradiation.
MATERIALS AND METHODS
Tissues and immunoperoxidase staining Four normal brain tissue specimens were obtained at autopsy. Tumor tissues from 5 astrocytomas, 10 anaplastic astrocytomas, 11 glioblastomas, 4 ependymomas, 12 medulloblastomas, 4 germinomas, and 3 malignant lymphomas were obtained from surgical specimens at Kobe University Hospital, fixed with 10% buffered formalin, and embedded in paraffin. Paraffin-embedded sections were deparaffinized with xylene and rehydrated in a graded ethanol series including phosphate-buffered saline (PBS), pH 7.4. Sections were incubated with 0.03% H 2 O 2 in methanol for 20 min, washed with PBS for 20 min and then incubated with 5% normal goat serum in PBS for 30 min followed by monoclonal anti-p21 antibody (#SC 817, Santa Cruz Biotechnology, Santa Cruz, CA) for 60 min at 37°C. They were washed with PBS for 20 min, then incubated with biotinylated goat anti-mouse IgG for 30 min at 37°C, washed again with PBS for 20 min, and incubated with avidinbiotin-peroxidase complex for 30 min at 37°C. Another wash with PBS was followed by peroxidase reaction with 0.06% diaminobenzidine and 0.01% H 2 O 2 in 50 mM TrisHCl (pH 7.0) for 5 min. Negative control sections were incubated with nonimmune mouse IgG instead of anti-p21 antibody. Three sections from each specimen were chosen for counting positive cells and calculation of the p21 positivity index. Cells were counted in groups including a total of 1000 nuclei, and numbers of stained cells were expressed as a percentage. Cell culture Human glioma cell lines (T-98G, U-251MG, and U-87MG) were obtained from the Japanese Cancer Research Resources Bank (Tokyo). The human medulloblastoma cell line, MED-3, was developed in our laboratory from a cerebellar medulloblastoma.
26) The U-87MG-S cells were obtained from U-87MG cells by single-cell dilution cloning using 96-well cell-culture plates. These cell lines were maintained in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS) and kanamycin sulfate (50 µg/ml) and grown in monolayer culture at 37°C. T-98G and U-251 MG cells were previously shown to contain a mutant p53 allele in codons 237 and 273, respectively, with concomitant loss of expression of a wild-type p53.
27) U-87MG cells have been shown to contain a wild-type, functional p53 allele, 27) as were MED-3 cells (unpublished data). Gene transfer The expression vector plasmid pcDNA/ p21 contains a 492-base-pair p21 coding region cDNA, a human cytomegalovirus promoter, an SV40 early polyadenylation signal, and a neomycin-resistance gene. 28) Cells near 70% confluence in 60-mm plates were transfected using 30 µg of lipofectin (Bethesda Research Laboratories Life Technologies, Gaithersburg, MD) and 10 µg of pcDNA/p21 for 24 h. At 2 days after transfection, G418
(600 µg/ml, Sigma Chemical, St. Louis, MO; cells not transfected die at this G418 concentration) was added. After pcDNA/p21 transfection and G418 treatment, G418-resistant colonies were isolated. Selected transfectants were maintained in medium as above with G418. A transfectant with pcDNA3.1 plasmid was used as a negative control. Analysis of p21 mRNA with reverse transcriptase-polymerase chain reaction (RT-PCR) Total RNA was prepared from cells using guanidium thiocyanate 29) and converted to a single-stranded cDNA by reverse transcriptase with oligo(dT) primer. Synthesized cDNA was used as a template in PCR with two sets of oligonucleotide primers. Human p21 cDNA was amplified by PCR using a previously reported method.
28) The primer pairs used were 5′-ATGTCAGAACCGGCTGGGGAT-3′ and 5′-GGGCT-TCCTCTTGGAGAAGAT-3′.
The PCR reaction was carried out in a thermal cycler for 30 cycles of 0.5 min at 94°C, 0.5 min at 54°C, and 1 min at 72°C. The PCR product using the primers for the glyceraldehyde 3-phosphate dehydrogenase gene (G3PDH) was used as an internal control. Western analysis of p21 Cells were dissolved with 500 µl of cell lysis buffer containing 1% Triton X-100, 1% sodium deoxycholate, 0.01% sodium dodecylsulfate (SDS), 0.15 M NaCl, 50 mM Tris-HCl (pH 7.4), and 2 mM phenylmethylsulfonyl fluoride. Lyophilized samples were dissolved at a protein concentration of 1 mg/ml in buffer containing 2.5% SDS, 5% 2-mercaptoethanol, and 0.01 M Tris-HCl (pH 8.0), and boiled for 5 min at 100°C. SDS-polyacrylamide gel electrophoresis (PAGE) and transfer of proteins onto nitrocellulose filters were performed using standard methods. The nitrocellulose filters were blocked with nonfat milk and then incubated with anti-p21 monoclonal antibody (Santa Cruz Biotechnology). Antibody binding to the filters was detected using the Amersham ECL system (Amersham Japan, Tokyo). Cell-cycle analysis Cell-cycle analysis was performed as previously described. 30) Cells in the exponential growth phase were labeled with 10 µM bromodeoxyuridine (BrdU) (Sigma Chemical) and incubated at 37°C for 2 h. The cells were washed twice with PBS, trypsinized, centrifuged, and washed twice with PBS/0.1% bovine serum albumin (BSA). Cell pellets (10 6 cells) were fixed with 70% ethanol for 30 min on ice. Before staining for BrdU with an anti-BrdU antibody conjugated to FITC (Becton Dickinson), the cell pellet was denatured in 2 N HCl/Triton X-100 for 30 min and then brought to pH 8.5 in 0.1 M Na 2 B 4 O 7 . Cells were suspended in 0.5% Tween 20/1.0% BSA/PBS for the antibody reaction. Before analysis, cell pellets were suspended in PBS containing 5 µg/ml propidium iodide. Cells (10 5 ) were analyzed using a fluorescence-activated cell sorter and Lysis II software (FACScan, Becton-Dickinson).
Colony-forming assays in semisolid agar medium Colony-forming assay was performed as reported previously. 31) A single cell suspension was made of 10 6 cells in the exponential growth phase with or without a prior single-dose γ-irradiation. The cells were suspended in 4 ml of 0.33% Special Noble Agar (Difco Laboratories, Detroit, MI) and plated on growth medium containing 0.5% soft agar. Fourteen days after cell plating, colonies exceeding 50 cells were counted. Plating efficiencies under 0.01% were considered negative for colony formation. Experiments were performed at least three times each and pooled data were fitted to a linear-quadratic equation to obtain estimates of the survival fraction at 2 Gy (SF 2 value). Statistical analysis of differences was carried out using Student's t test. A 60 Co source was used for γ-irradiation of cells. The dose rate at the time of irradiation was 1.56 Gy/min. DNA fragmentation For this assay, we used a modification of the protocol described by Duke et al. 32) Fragmentation of cellular DNA was measured 24 h after a 6 Gy dose of γ-irradiation as above. Adherent and nonadherent cells were pooled, washed in PBS, and suspended in ice-cold buffer containing 0.15 M NaCl, 10 mM Tris (pH 4 age of cells containing apoptotic nuclei was determined by fluorescence microscopy at a magnification of ×400. Cells with three or more condensed chromatin fragments were considered apoptotic. For each sample 500 to 700 cells were counted.
RESULTS

Expression of p21 in human brain tumors
In this study the 4 normal brain samples showed p21 expression. p21-positive cells were seen mainly among neurons and glial cells (Fig. 1) , but not vascular endothelial cells. The 49 brain tumors examined all showed varying degrees of p21 expression. Astrocytic tumors, such as astrocytoma, ana- Fig. 2 . Expression of p21 in medulloblastoma (C and D), malignant lymphoma (E), and germinoma (F); compare with the higher levels of expression in anaplastic astrocytoma (A) and gliosis (B). Immunohistochemical staining with anti-p21 antibody, original magnification, ×400. plastic astrocytoma, and glioblastoma ( Fig. 1) showed high positivity indices for p21 (means, 58.15, 66.92, and 71.97%, respectively; Table I ). The positivity index of p21 in astrocytic tumors was significantly higher than in normal brain (P<0.05). No relationship was seen between positivity index for p21 and histologic maligancy of astrocytic tumors (P>0.05). In contrast, radiosensitive tumors such as medulloblastoma, germinoma, and primary malignant lymphoma (Fig. 2) showed low positivity indices for p21 (15.21, 6 .488, and 9.85%, respectively; Table I ). The positivity indices for radiosensitive tumor type were significantly different from those of astrocytic tumors (P<0.01). These results suggest a relationship between p21 expression and radiosensitivity. Characterization of human brain tumor cell lines transfected with p21 gene Investigations of the role of p21 in the radiosensitivity of brain tumors were conducted in two human astrocytoma cell lines with mutant-type p53, U-251MG and T-98G cells, and in two wild-type p53-positive cell lines, U-87MG-S and MED-3. U-251MG and T-98G cells showed higher basal levels of p21 expression than those seen in U-87MG-S and MED-3 cells, suggesting that p21 expression in human brain tumor cells is p53-independent. In stable p21 transfectants, p21 mRNA (Fig.  3A) and p21 (Fig. 3B ) were confirmed to be overexpressed. These transfectants with an exogenous p21 gene showed growth delay and phenotypic differentiation.
28)
Cell cycle alterations after transfection of p21 (Table  II) Cell cycle patterns were analyzed in parent cells and in transfectants using a BrdU incorporation assay. 30) Intrinsic sensitivity of cells to γ-irradiation has been reported to be a function of cell cycle phase at exposure. In some studies, [33] [34] [35] cells were more sensitive in the G2/M and early S phases. Mean fractions of cells in the G1 phase for MED-3 and U-87MG-S were 12.8% and 31.8%, respectively. In contrast, the G1 phase in lines representing radioresistant tumors, U-251MG and T-98G, accounted for 50.7% and 60.3% of cells, respectively. Fractions of transfectants in the G1 phase were much larger than in the radiosensitive parent cells. In radioresistant lines, MED-3/p21 and U-87MG-S/p21, G1 fractions were 64.2% and 63.8%, respectively; U-251MG/p21 and T-98G/p21 cells had G1 fractions of 66.6% and 72.0% respectively, which are elevated compared to the parent cells. Decreased sensitivity to γ γ γ γ-irradiation after transfection with p21 Clonogenic survival curves are shown in Fig. 4 Fig. 3 . Expression of p21 mRNA and p21 protein in parent cells and p21 transfectants. A: p21 mRNA bands after amplification. Products generated using glyceraldehyde 3-phosphate dehydrogenase primers were used as an internal control. B: expression levels of p21 protein in parent cells and p21 transfectants analyzed by gel electrophoresis and western blotting. mentation assay (Fig. 5 ) revealed DNA ladder formation in radiosensitive MED-3 and U-87MG-S cells after γ-irradiation, induction of p21 overexpression resulted in a marked reduction of DNA ladder formation in MED-3 and U-87MG-S cells following γ-irradiation. Quantitative analysis of apoptotic cells using Hoechst 33258 staining showed more apoptotic nuclei in MED-3 and U-87MG-S cells than in radioresistant cells after γ-irradiation (Table  IV) . The p21-overexpressing cells showed much greater inhibition of γ-irradiation-induced apoptosis than the parent cells, especially among radiosensitive lines (Fig. 6 ).
DISCUSSION
Expression of p21 in brain tumor tissues This study investigated the role of p21 in the radiosensitivity of human brain tumors. We found high p21 expression in radioresistant astrocytic tumors, but low expression in radiosensitive medulloblastomas, germinomas, and primary malignant lymphomas. No previous reports have analyzed the relationship between p21 expression in tumor tissue and radiosensitivity. In our study, a striking inverse relationship was evident between p21 expression and radiosensitivity in human brain tumors. It has been reported that p21 expression is absent in most fetal tissues, in contrast to adults. 36) Generally, fetal tissues are thought to be more radiosensitive than adult tissues. Jung et al. 22) have reported that p21 was elevated in most gliomas tested, regardless of histologic grade, and suggested that both p53-dependent and p53-independent mechanisms are involved in p21 expression. Similarly, we found no relationship between positivity index for p21 and histologic maligancy of astrocytic tumors. These results suggest that p21 expression in human astrocytic tumors is partially p53-independent. The effect of p21 overexpression on radiosensitivity in glioma cells Transfection of p21 cDNA induced stable overexpression of p21 in brain tumor cells with mutanttype p53 (U-251MG and T-98G), as well as in those with wild-type p53 (U-87MG-S and MED-3). High levels of p21 expression enhanced clonogenic survival and caused suppression of apoptosis after γ-irradiation, irrespective of the tumor cell line's p53 status. Radiosensitive U-87MG-S and MED-3 cells showed low basal p21 levels despite having wild-type p53, while radioresistant U-251MG and T-98G cells showed relatively high p21 expression. Recently, some p53 mutants found in tumors have shown a subtle transcriptional defect affecting bax induction, but not p21 induction. 37, 38) Some in vivo and in vitro studies have shown that p21 expression is actively controlled through p53-independent pathways. [39] [40] [41] The suggestion was made that some p53 mutants retain the ability to activate p21-mediated G1 arrest and protection from apoptosis, but not bax-mediated apoptosis. Expression of p21 mRNA and the corresponding protein appeared to be p53-independent in human brain tumor cells.
We observed that overexpression of p21 induced G1 arrest and prevention of γ-irradiation-induced apoptosis, suggesting that DNA repair occurs during the G1 phase and that the increasing effect of p21 on radioresistance may result from cell cycle arrest in the G1 phase. A recent study has shown that cells deficient in p21 displayed a markedly different response to DNA-damaging agents than cells with an intact p21 checkpoint. Cells with intact p21 entered stable arrest following DNA damage by γ-irradiation or chemotherapeutic agents, while cells with a defective p21 response underwent apoptosis which apparently was induced by uncoupling between mitosis and the S phase after DNA damage. Cells without functioning p21 continued to undergo DNA synthesis in the absence of mitosis, culminating in apoptosis. 17) However, Shim et al. 42) have recently reported an inhibitory effect of p21 on c-Jun N-terminal kinase (JNK), a key regulatory protein in multiple stress-activated pathways. As JNK has recently been implicated in apoptosis, its interaction with p21 raises the intriguing possibility that p21-mediated inhibition of apoptosis may be linked directly to its inhibitory effect on JNK. More recently, p21 has been shown to permit repair of DNA damage derived from [1,3-bis(2-chloroethyl)-1-nitrosourea or cis-platinum, as well as protecting glioma cells from chemotherapy-induced apoptosis. The p21 protein was suggested to participate in nuclear factor κB-dependent gene expression through p300, as well as in the expression of chemoresistance genes. 43, 44) Further, the Fas-initiated death signaling was endogenously prevented by p21-binding to procaspase 3, resulting in cell survival. 45) In summary, we think that p21 has various inhibitory functions against apoptotic signals, including those derived from γ-irradiation, and p21 may promote survival of glioma cells exposed to a broad range of DNA-damaging agents; the p21 status of gliomas might predict general responsiveness to such agents. Furthermore, p21 may represent an important new target for radiosensitization protocols, possibly involving antisense oligonucleotides directed against p21.
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